THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 113 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $214,960 | -16.8% | 24,937 | -0.2% | 0.00% | – |
| Q2 2023 | $258,503 | -4.8% | 24,988 | -0.2% | 0.00% | – |
| Q1 2023 | $271,593 | +120.5% | 25,043 | +127.9% | 0.00% | – |
| Q4 2022 | $123,179 | +9.9% | 10,988 | -50.0% | 0.00% | – |
| Q3 2022 | $112,112 | +12.1% | 21,978 | +98.5% | 0.00% | – |
| Q2 2022 | $100,000 | -4.8% | 11,074 | +0.7% | 0.00% | – |
| Q1 2022 | $105,000 | -13.9% | 10,996 | -0.0% | 0.00% | – |
| Q4 2021 | $122,000 | – | 10,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 10,898,879 | $264,297,000 | 23.51% |
| Foundation Asset Management, LP | 399,537 | $9,689,000 | 3.59% |
| Cormorant Asset Management, LP | 1,300,000 | $31,525,000 | 2.35% |
| Baupost Group | 9,309,168 | $225,747,000 | 2.18% |
| Old West Investment Management, LLC | 109,320 | $2,651,000 | 1.53% |
| SENZAR ASSET MANAGEMENT, LLC | 187,856 | $4,555,000 | 1.44% |
| Chescapmanager LLC | 350,631 | $8,503,000 | 1.27% |
| Virtus ETF Advisers LLC | 32,989 | $800,000 | 0.69% |
| Rock Springs Capital Management LP | 652,600 | $15,826,000 | 0.68% |
| NJ State Employees Deferred Compensation Plan | 34,142 | $828,000 | 0.15% |